Colistin therapy in critically ill patients with chronic renal failure and its effect on development of renal dysfunction

International Journal of Antimicrobial Agents

Volumn 39, Issue 2, 2012, Pages 142-145

  Turkoglu, Melda ^a   Dizbay, Murat ^a   Çiftçi, Arzu ^a   Aksakal, F Nur ^a   Aygencel, Gülbin ^a  

^a GAZI UNIVERSITY   (Turkey)

Author keywords

Colistin; Critically ill; Effectiveness; Mortality; Renal failure

Indexed keywords

CARBAPENEM; COLISTIN; RIFAMPICIN;

ACINETOBACTER INFECTION; ADULT; APACHE; ARTICLE; CASE CONTROL STUDY; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DEMOGRAPHY; DRUG EFFICACY; DRUG WITHDRAWAL; FEMALE; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEPHROTOXICITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSEUDOMONAS INFECTION; SEX DIFFERENCE; UNIVERSITY HOSPITAL;

ACINETOBACTER BAUMANNII; ACUTE KIDNEY INJURY; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; APACHE; BACTERIAL INFECTIONS; CASE-CONTROL STUDIES; COLISTIN; CRITICAL ILLNESS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PSEUDOMONAS AERUGINOSA; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84855507301     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2011.10.006     Document Type: Article

References (14)

1. Falagas ME, Kasiakou SK. Colistin: the revival of polymyxins for the management of multidrug-resistant Gram-negative bacterial infections. Clin Infect Dis 2005;40:1333-41. (Pubitemid 40570245)
2. Pintado V, San Miguel LG, Grill F, Mejía B, Cobo J, Fortún J, et al. Intravenous colistin sulphomethate sodium for therapy of infections due to multidrugresistant Gram-negative bacteria. J Infect 2008;56:185-90.
3. Cheng CY, Sheng WH, Wang JT, Chen YC, Chang SC. Safety and efficacy of intravenous colistin (colistin methanesulphonate) for severe multidrug-resistant Gram-negative bacterial infections. Int J Antimicrob Agents 2010;35:297-300.
4. Hartzell JD, Neff R, Ake J, Howard R, Olson S, Paolino K, et al. Nephrotoxicity associated with intravenous colistin (colistimethate sodium) treatment at a tertiary care medical center. Clin Infect Dis 2009;48:1724-8.
5. Paul M, Bishara J, Levcovich A, Chowers M, Goldberg E, Singer P, et al. Effectiveness and safety of colistin: prospective comparative cohort study. J Antimicrob Chemother 2010;65:1019-27.
6. World Health Organization Collaborating Centre for Drug Statistics Methodology. Anatomical therapeutic chemical defined daily dose (ATC/DDD) index. http://www.whocc.no/atcddd/ [accessed July 2004].
7. Horan T, Andrus M, Dudeck M. CDC/NHSN surveillance definition of health careassociated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008;36:309-32. (Pubitemid 351763841)
8. Souli M, Galani I, Giamarellou H. Emergence of extensively drug-resistant and pandrug-resistant Gram-negative bacilli in Europe. Euro Surveill 2008;13, pii: 19045.
9. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985;13:818-29. (Pubitemid 15250137)
10. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.
11. Samimagham HR, Kheirkhah S, Haghighi A, Najmi Z. Acute kidney injury in intensive care unit: incidence, risk factors and mortality rate. Saudi J Kidney Dis Transpl 2011;22:464-70.
12. Piccinni P, Cruz DN, Gramaticopolo S, Garzotto F, Dal Santo M, Aneloni G, et al. Prospective multicenter study on epidemiology of acute kidney injury in the ICU:a critical care nephrology Italian collaborative effort (NEFROINT). Minerva Anestesiol 2011;77:1072-83.
13. Eyler RF, Mueller BA. Antibiotic dosing in critically ill patients with acute kidney injury. Nat Rev Nephrol 2011;7:226-35.
14. Falagas ME, Rafailidis PI, Ioannidou E, Alexiou VG, Matthaiou DK, Karageorgopoulos DE, et al. Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a retrospective cohort study of 258 patients. Int J Antimicrob Agents 2010;35: 194-9.